Syneos Health (SYNH) Tops Q4 EPS by 2c; Guides FY23 Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts SYNH Hot Sheet
Join SI Premium – FREE
Syneos Health (NASDAQ: SYNH) reported Q4 EPS of $1.23, $0.02 better than the analyst estimate of $1.21. Revenue for the quarter came in at $1.36 billion versus the consensus estimate of $1.29 billion.
GUIDANCE:
Syneos Health sees Q1 2023 EPS of $3.26-$3.53, versus the consensus of $3.89. ObsEva SA sees Q1 2023 revenue of $4.975-5.175 billion, versus the consensus of $5.13 billion.
For earnings history and earnings-related data on Syneos Health (SYNH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Kotak Mahindra Bank Ltd. (KMB:IN) PT Raised to INR492 at JPMorgan
- AI-powered cyber threats light a fire under cybersecurity stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
